Publication

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, et al. 2019. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 125:18–44. doi:10.1002/cncr.31719.

Nfonsam VN, Nfonsam LE, Chen D, Omesiete PN, Cruz A, Runyan RB, Jandova J. 2019. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients. J Surg Res. 233:297–303. doi:10.1016/j.jss.2018.08.021.

Kunihiro AG, Brickey JA, Frye JB, Luis PB, Schneider C, Funk JL. 2019. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues. J Nutr Biochem. 63:150–156. doi:10.1016/j.jnutbio.2018.09.021.

Lu Y, Gutgesell LM, Xiong R, Zhao J, Li Y, Rosales CI, Hollas M, Shen Z, Gordon-Blake J, Dye K, et al. 2019. Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast Cancer. J Med Chem. 62:11301–11323. doi:10.1021/acs.jmedchem.9b01580.

Zhang Y, Huynh JM, Liu G-S, Ballweg R, Aryeh KS, Paek AL, Zhang T. 2019. Designing combination therapies with modeling chaperoned machine learning. PLoS Comput Biol. 15:e1007158. doi:10.1371/journal.pcbi.1007158.

Zhou J, Jenkins TG, Jung AM, Jeong KS, Zhai J, Jacobs ET, Griffin SC, Dearmon-Moore D, Littau SR, Peate WF, et al. 2019. DNA methylation among firefighters. PLoS One. 14:e0214282. doi:10.1371/journal.pone.0214282.

Almutairi AR, Alkhatib NS, Oh M, Curiel-Lewandrowski C, Babiker HM, Cranmer LD, McBride A, Abraham I. 2019. Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma. JAMA Dermatol. 155:22–28. doi:10.1001/jamadermatol.2018.3958.

Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, Meysamie A, Yi SK, Iwano S, Bybel B, et al. 2019. Effect of blood glucose level on standardized uptake value (SUV) in F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 46:224–237. doi:10.1007/s00259-018-4194-x.

Garland LL, Guillen-Rodriguez J, Hsu C-H, Yozwiak M, Zhang HH, Alberts DS, Davis LE, Szabo E, Merenstein C, Lel J, et al. 2019. Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial. Cancer Prev Res (Phila). 12:809–820. doi:10.1158/1940-6207.CAPR-19-0036.

Lance P, Pearson T, Caporaso JG, Yellowhair M, Bokulich NA, Padi M, Roe DJ, Wertheim BC, Linhart M, Martinez JA, et al. 2019 Jan. Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development. Cancer Med. doi:10.1002/cam4.1965.

Xu P, Ganaie SS, Wang X, Wang Z, Kleiboeker S, Horton NC, Heier RF, Meyers MJ, Tavis JE, Qiu J. 2019. Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development. Antimicrob Agents Chemother. 63. doi:10.1128/AAC.01879-18.

Liu X, Craig ZR. 2019. Environmentally relevant exposure to dibutyl phthalate disrupts DNA damage repair gene expression in the mouse ovary†. Biol Reprod. 101:854–867. doi:10.1093/biolre/ioz122.

Florea A, Brown HE, Harris RB, Oren E. 2019. Ethnic Disparities in Gastric Cancer Presentation and Screening Practice in the United States: Analysis of 1997-2010 Surveillance, Epidemiology, and End Results-Medicare Data. Cancer Epidemiol Biomarkers Prev. 28:659–665. doi:10.1158/1055-9965.EPI-18-0471.

Tosun NL, Fieberg AM, Eberly LE, Harrison KA, Tipp AR, Allen AM, Allen SS. 2019. Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial. Addiction. 114:1800–1813. doi:10.1111/add.14645.

Stern JH, Arriaga Y, Gupta A, Verma U, Karri S, Syed S, Khosama L, Mansour J, Meyer J, Scherer PE, et al. 2019. Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?. Pancreas. 48:e1-e3. doi:10.1097/MPA.0000000000001208.

Lake AD, Hardwick RN, Leamon CP, Low PS, Cherrington NJ. 2019. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis. Toxicol Appl Pharmacol. 368:49–54. doi:10.1016/j.taap.2019.02.009.

Rubenstein CS, Gard JMC, Wang M, McGrath JE, Ingabire N, Hinton JP, Marr KD, Simpson SJ, Nagle RB, Miranti CK, et al. 2019. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer. Cancer Res. 79:4703–4714. doi:10.1158/0008-5472.CAN-19-0868.

Fujimaki K, Li R, Chen H, Della Croce K, Zhang HH, Xing J, Bai F, Yao G. 2019. Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch. Proc Natl Acad Sci U S A. 116:22624–22634. doi:10.1073/pnas.1915905116.

Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, Guild V, Grant-Kels JM, Halpern AC, Johnson TM, et al. 2019. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 80:208–250. doi:10.1016/j.jaad.2018.08.055.

Hendricks WPD, Briones N, Halperin RE, Facista S, Heaton PR, Mahadevan D, and Kim S. (2019) PD-1-associated gene expression signature of neoadjuvant trastuzumab-treated tumors correlates with patient survival in HER2-positive breast cancer Cancers. 2019.

Buehler J, Carpenter E, Zeltzer S, Igarashi S, Rak M, Mikell I, Nelson JA, Goodrum F. 2019. Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency. PLoS Pathog. 15:e1008037. doi:10.1371/journal.ppat.1008037.

Woo H-H, Chambers SK. 2019. Human ALKBH3-induced mA demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. Biochim Biophys Acta Gene Regul Mech. 1862:35–46. doi:10.1016/j.bbagrm.2018.10.008.

Xi Y, Harwood S, Wise LM, Purdy JG. 2019. Human Cytomegalovirus pUL37x1 Is Important for Remodeling of Host Lipid Metabolism. J Virol. 93. doi:10.1128/JVI.00843-19.

Toth RK, Tran JD, Muldong MT, Nollet EA, Schulz VV, Jensen CC, Hazlehurst LA, Corey E, Durden D, Jamieson C, et al. 2019. Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC. Am J Clin Exp Urol. 7:297–312.

Martelly W, Fellows B, Senior K, Marlowe T, Sharma S. 2019. Identification of a noncanonical RNA binding domain in the U2 snRNP protein SF3A1. RNA. 25:1509–1521. doi:10.1261/rna.072256.119.